CVS Health Corporation
CVS
$67.77
-$0.73-1.07%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -9.51% | 18.94% | -11.00% | -8.48% | 168.53% |
| Total Depreciation and Amortization | 0.62% | 2.08% | 10.29% | -4.03% | -0.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 280.00% | -59.73% | -43.56% | -30.89% | -42.64% |
| Change in Net Operating Assets | -725.68% | -126.58% | -31.78% | 170.69% | -152.82% |
| Cash from Operations | -197.05% | -54.03% | -20.57% | 481.05% | -121.40% |
| Capital Expenditure | -67.16% | 7.78% | 39.94% | -43.02% | -18.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -566.67% | 99.81% | -32.22% | -88,575.00% | -33.33% |
| Divestitures | -- | -- | -- | -- | 4,426.67% |
| Other Investing Activities | -1.44% | 46.80% | 10.32% | -327.45% | 56.41% |
| Cash from Investing | -61.09% | 92.56% | -21.71% | -7,054.62% | 85.22% |
| Total Debt Issued | 120.00% | -109.13% | 83.95% | -- | -- |
| Total Debt Repaid | 54.38% | 85.26% | -1,674.86% | -2,162.50% | 99.40% |
| Issuance of Common Stock | -71.31% | 408.33% | -75.00% | 134.15% | -74.69% |
| Repurchase of Common Stock | -25.00% | 96.97% | 93.57% | -33.86% | -19,062.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 2.01% | -2.05% | -8.34% | 0.96% |
| Other Financing Activities | 110.11% | -1,371.43% | 105.47% | -420.00% | 100.00% |
| Cash from Financing | 63.96% | -174.38% | 33.02% | 224.65% | 32.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -544.95% | 9.18% | -150.18% | 138.75% | -183.49% |
